Tumour necrosis factor gene polymorphisms as severity markers in rheumatoid arthritis

Annals of the Rheumatic Diseases

Volumn 58, Issue SUPPL. 1, 1999, Pages

  Verweij, Cornelis L ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

TUMOR NECROSIS FACTOR;

CYTOKINE PRODUCTION; DNA POLYMORPHISM; GENE FREQUENCY; GENE LOCUS; GENOTYPE; HUMAN; PRIORITY JOURNAL; PROMOTER REGION; REPORTER GENE; REVIEW; RHEUMATOID ARTHRITIS;

EID: 0032731689     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: 10.1136/ard.58.2008.i20     Document Type: Review

References (52)

1. Silman AJ, MacGregor AJ, Thomson W, et al. Twin concordance rates for rheumatoid arthritis: results from a nationwide study. J Rheumatol 1993;32:903-7.
2. Lawrence JS. Rheumatoid arthritis nature or norture? Ann Rheum Dis 1970;29:357-79.
3. Aho K, Koskenvuo M, Tuominen J, Kaprio J. Occurrence of rheumatoid arthritis in a nationwide series of twins. J Rheumatol 1986;13:899-902.
4. Cornelis F, Fauré S, Martinez M, et al. Rheumatoid arthritis genome scan and pretative autoimmunity locus. Arthritis Rheum 1997;40:S329.
5. Gregersen PK, Silver J, Winchester RJ. The shared epitope hypothesis: An approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis. Arthritis Rheum 1987;30:1205-13.
6. Van Zeben, Hazes JMW, Zwinderman AH, et al. Association of HLA-DR4 with a more progressive disease course in patients with rheumatoid arthritis. Arthritis Rheum 1991; 34:822-30.
7. Weynand CM, Goronzy JJ. HLA-DRB1 alleles as severity markers in RA. Bull Rheum Dis 1994;43:5-8.
8. Wordsworth P, Bell J. Polygenic susceptibility in rheumatoid arthritis. Ann Rheum Dis 1991;50:343-6.
9. Brennan FM, Maini RN, Feldmann M. TNF alpha-A pivotal role in rheumatoid arthritis. Br J Rheumatol 1992; 31:293-8.
10. Elliott MJ, Maini RN, Feldmann M, et al. Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumor necrosis factor alpha. Arthritis Rheum 1993;36: 1681-90.
11. Keffer J, Probert L, Cazlaris H, et al. Transgenic mice expressing human tumor necrosis factor: a predictive model of arthritis. EMBO 1991;10:4025-31.
12. Westendorp RGJ, Langermans JAM, Huizinga TWJ, et al. Genetic influence on cytokine production and fatal meningococcal disease. Lancet 1997;349:170-3.
13. Jacob CO, Fronek Z, Lewis GD, et al. Heritable major histo-compatibility complex class II-associated differences in production of TNFα: relevance to genetic predisposition to systemic lupus erythematosus. Proc Natl Acad Sci USA 1990;87:1233-7.
14. Bendtzen K, Morling N, Fonsgaard A, et al. Association between HLA-DR2 and production of tumor necrosis factor α and interleukin 1 by mononuclear cells activated by lipopolysaccharide. Scand J Immunol 1988;28:599-606.
15. Pociot F, Briant L, Jongeneel CV, et al. Association of TNF and class II MHC alleles with the secretion of TNF-alpha and TNF-beta by human mononuclear cells: a possible link to insulin-dependent diabetes mellitus. Eur J Immunol 1993;23:224-32.
16. Campbell RD, Trowsdale J, Raquoussis J. Map of the human major histocompatibility complex. Immunol Today 1993;14:349-52.
17. Fernandes DM, Baldwin CL. Interleukin 10 downregulates protective immunity to Brucella abortus. Infect Immun 1995;63:1130-3.
18. Gazznelli RT, Wysocka M, Hieny S, et al. In the absence of endogenous IL-10, mice acutely infected with Toxoplasma gondii succumb to a lethal immune response dependent on CD4+ T cells and accompanied by overproduction of IL-12, IFNy, and TNFa. J Immunol 1996;157:798-805.
19. Alexander HR, Sheppard BC, Jensen JC, et al. Treatment with recombinat human tumor necrosis factor alpha protects rats against lethality, hypotension, and hypothermia of gram-negative sepsis. J Clin Invest 1991;88:34-9.
20. Rothe J, Lesslauer W, Lotscher H, et al. Mice lacking the tumour necrosis factor receptor I are resistant to TNF-mediated toxicity but highly susceptible to infection by Listeria monocytogenes. Nature 1993;364:798-802.
21. Kuhn R, Lohler J, Rennick D, Rajewsky K, Muller W. Interleukin-10-deficient mice develop chronic enterocolitis. Cell 1993;75:263-9.
22. Jongeneel CV, Briant L, Udalova IA, et al. Extensive genetic polymorphism in the human tumor necrosis factor region and relation to extended HLA haplotypes. Proc Natl Acad Sci USA 1991;88:9717-21.
23. Udalova IA, Nedospasov SA, Webb GC, Chaplin DD, Turetskaya RL. Highly informative typing of the human TNF locus using six adjacent polymorphic markers. Genomics 1993;16:180-6.
24. Messer G, Spengler U, Jung MC, et al. Polymorphic structure of the tumor necrosis factor (TNF) locus: An Ncol polymorphism in the first intron of the human TNF-β gene correlates with a variant amino acid in position 26 and a reduced level of TNF-β production. J Exp Med 1991;173:209-19.
25. Partanen J, Koskimies S. Low degree of DNA polymorphism in the HLA-linked lymphotoxin (tumour necrosis factor β) gene. Scand J Immunol 1988;28:313-16.
26. Ferencir S, Lindemann M, Horsthemke B, Grosse-Wilde H. A new restriction fragment length polymorphism of the human TNF-β gene detected by AspHI digest. Eur J Immunogenet 1992;19:425-30.
27. Wilson AG, de Vries N, Pociot F, et al. An allelic polymorphism within the human tumor necrosis factor alpha promotor region is strongly associated with HLA A1, B8 and DR3 alleles. J Exp Med 1993;177:557-60.
28. D'Alfonso S, Richiardi P,M. A polymorphic variation in a putative regulation box of the TNFα promotor region. Immunogenetics 1994;39:150-4.
29. Brinkman BMN, Kaijzel EL, Huizinga TWJ, et al. Detection of a C-insertion polymorphism within the human tumor necrosis factor alpha (TNFA) gene. Hum Genet 1995;96: 493.
30. Hamman A, Mantzoros C, Vidal-Puig A, Flier JS. Genetic variability in the TNFα-promoter is not associated with type II diabetes mellitus (IDDM). Biochem Biophys Res Commun 1995;211:833-9.
31. Uglialoro AM, Turhay D, Pesavento PA, et al. Identification of three new single nucleotide polymorphisms in the human tumor necrosis factor alpha gene promoter. Tissue Antigens 1998;52:359-67.
32. Higuchi T, Seki N, Kamizono S, et al. Polymorphism of the 5'-flanking region of the human tumor necrosis (TNF) alpha gene in Japanese. Tissue Antigens 1998;51:605-12.
33. D'Alfonso S, Momigliano RP. An intragenic polymorphism in the human tumor necrosis factor alpha (TNFA) chain-encoding gene. Immunogenetics 1996;44:321-22.
34. Kaijzel EL, van Krugten MV, Brinkman BMN, et al. Functional analysis of a human tumor necrosis factor alpha promoter polymorphism related to joint damage in rheumatoid arthritis. Mol Med 1998;4:724-33.
35. Miller WL, Morel Y. The molecular genetics of 21-hydroxylase deficiency. Ann Rev Genet 1989;23:371-93.
36. Brinkman BMN, Giphart MJ, Vorhoef A, et al.Tumor necrosis factor u-308 gene variants in relation to major histocompatibility complex alleles and Felty's syndrome.Hum Immunol 1994;41:259-67.
37. McGuire W, Hill AVS, Allsopp CEM, Greenwood BM, Kwiatkowski D. Variation in the TNFα promoter region associated with susceptibility to cerebral malaria. Nature 1994;371:508-12.
38. Cabrera M, Shaw MA, Sharples C, et al. Polymorphism in tumor necrosis factor genes associated with mucocutaneous leishmaniasis. J Exp Med 1995;182:1259-64.
39. Hohler T, Kruger A, Schneider PM, et al. A TNF-alpha promoter polymorphism is associated with juvenile onset psoriasis and psoriatic arthritis. J Invest Dermatol 1997; 109:562-5.
40. Mullighan CG, Fanning GC, Chapel HM, Welsh KI. TNF and lymphotoxin-alpha polymorphisms associated with common variable immunodeficiency: role in the pathogenesis of granulomatous disease. J Immunol 1997;159:6236-41.
41. Mulcahy B, Waldronlynch F, Mcdermott MF, et al. Genetic variability in the tumor necrosis factor- lymphotoxin region influences susceptibility to rheumatoid arthritis. Am J Hum Genet 1996;59:676-83.
42. Ball D, Gourley IS, Kostijn D, et al. Genetic analysis of multiplex rheumatoid arthritis families. Arthritis Rheum 1996; 39:S73.
43. Hajeer AH, Worthington J, Silman AJ, Ollier WER. Association of tumor necrosis factor microsatellites polymorphisms with HLA-DRB1 *04-bearing haplotypes in rheumatoid arthritis patients. Arthritis Rheum 1996;39: 1109-14.
44. van Krugten MV, Huizinga TWJ, Kaijzel EL, et al. Association of the TNF +489 polymorphism with susceptibility and radiographic damage in rheumatoid arthritis patients. Genes Immunity (in press).
45. Brinkman BMN, Huizinga TWJ, Kurban SS, et al. Tumour necrosis factor alpha gene polymorphisms in rheumatoid arthritis: association with susceptibility to, or severity of, disease? Br J Rheumatol 1997;36:516-21.
46. Criswell LA, Mu H, Such CL, King MC. Tumor necrosis factor (TNF) microsatellite polymorphism is associated with long-term RA outcomes. Arthritis Rheum 1997;9 (suppl):S1787.
47. Brinkman BMN, Zuijdgeest D, Kaijzel EL, Breedveld FC, Verweij CL. Relevance of the tumor necrosis factor alpha (TNF alpha) - 308 promoter polymorphism in TNF alpha gene regulation. J Inflamm 1996;46:32-41.
48. Brinkman BMN, Huizinga TWJ, Breedveld FC, Venweij CL. Allele - specific quantification of TNFα transcripts in rheumatoid arthritis. Hum Genet 1996;97:813-8.
49. Stuber F, Udalova IA, Book M, et al. -308 tumor necrosis factor (TNF) polymorphism is not associated with survival in severe sepsis and is unrelated to lipopolysaccharide inducibility of the human TNF promoter. J Inflamm 1996; 46:42-50.
50. Wilson AG, Symons JA, McDowell TL, McDevitt HO, Duff GW. Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation. Proc Natl Acad Sci USA 1997;94:3195-9.
51. Kroeger KM, Carville KS, Abraham LJ. The -308 tumor necrosis factor promoter polymorphism effects transcription. Mol Immunol 1997;34:391-9.
52. Braun N, Michel U, Ernst BP, et al. Gene polymorphism at position -308 of the tumor necrosis factor alpha (TNF-alpha) gene in multiple sclerosis and its influence on the regulation of TNF alpha production. Neurosci Lett 1996;215:75-8.